Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CytoCore Inc. (CytoCore), an in vitro diagnostics company, has signed agreement with Amsino International, Inc. (Amsino), a manufacturer and distributor of medical devices. Under the agreement, Amsino will direct worldwide sales of CytoCore’s SoftPAP cervical cell collector kits through their channel of distribution partners. Amsino will also sell CytoCore’s products directly to laboratories, and physicians and other medical providers through their direct sales force.
Subscribe to our email newsletter
Under the agreement, Amsino will be responsible for transportation and warehousing logistics, order management, customer service, quality assurance and bill collection.
Robert McCullough, chief executive officer of CytoCore, commented, “This agreement with Amsino will significantly enhance SoftPAP’s presence in the market and help generate increased sales. Amsino is a leading distributor of medical devices and has strong relationships with well-recognized end user distributors including PSS, McKesson, and Henry Schein, among others. Our partnership with Amsino is a significant step up in helping CytoCore gain traction in expanding the sales of the SoftPAP cervical cell collector kit which will provide value individually to the patient, physician and laboratory during the collection and analysis of a woman’s pap examination. We look forward to working with Amsino to explore opportunities to leverage additional areas of their expertise with regard to CytoCore’s present and future product lines.
“Our recently announced partnership with Synermed Select Partners, Inc. and their preservative provides CytoCore the ability to offer in ‘kit form’ a significant upgrade to the SoftPAP collector. Our new product combination was developed in direct response to requests from several of our domestic and international partners. This new relationship with Amsino gives us the marketing and distribution reach to bring our SoftPAP product offering to those domestic and international markets where we know it will be competitive and is needed, and the combination should enhance our current capital raising efforts to fund our future growth. We are excited about the impact these two new developments can have for CytoCore sales this year and beyond.” McCullough said.
Phil Kelsey, Amsino president of global sales stated “We believe the unique SoftPAP cervical cell collector kit product will be accepted by health professionals and patients worldwide because of the diagnostic accuracy and the significant reduction of discomfort associated with current methods of collecting a pap sample. We are excited about our relationship with CytoCore and their forthcoming ‘CytoCore solutions™’ product line which comprises the imminent launch of the SoftPAP cervical cell collector kit.”